← FDA Drug Approvals (Drugs@FDA)

RESCRIPTOR

NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 1997-04-04

Drug application

FDA Application #

NDA020705

Application type

New Drug Application

Brand name

RESCRIPTOR

Generic name

Delavirdine Mesylate

Active ingredients

DELAVIRDINE MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

VIIV HLTHCARE

First approval

1997-04-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown